Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Browse Lab Results > 2005-0008

Trial Summary

About CDAS Project, PI, Publications: Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer

Datasets


Site: Pancreas

Inclusion Criteria:

  • No History of Pancreatic Cancer
  • No Rare Cancers in Controls
  • Pre-Diagnostic Serum Available (Perfect for Controls)
  • Pre-Diagnostic Serum within 3 years of Dx for Cases
  • No Endocrine Pancreatic Cancers

Matching Factors:

  • Gender
  • Age at Serum Collection (5 year intervals)
  • Calendar Year of Serum Collection
  • Study Year of Serum Collection

Match Ratio: 4 to 1

Match Technique: Frequency matching only non-cases as controls.


Analytes:

  • Brain-Derived Neurotrophic Factor
  • Cancer Antigen 19-9
  • Cancer Antigen 72-4
  • Carcinoembryonic antigen
  • Follicle Stimulating Hormone
  • Growth Hormone
  • Osteocalcin
  • Osteopontin
  • Osteoprotegerin
  • Plasminogen activator inhibitor-1

Number of Cases: 135

Number of Controls: 540